Viewing StudyNCT01767129



Ignite Creation Date: 2024-05-06 @ 1:14 AM
Last Modification Date: 2024-10-26 @ 11:01 AM
Study NCT ID: NCT01767129
Status: COMPLETED
Last Update Posted: 2022-04-29
First Post: 2013-01-09

Brief Title: Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinsons Disease Patients
Sponsor: Avanir Pharmaceuticals
Organization: Avanir Pharmaceuticals

Conditions & Keywords Data

Conditions:
Name
Parkinsons Disease
Dyskinesia
Keywords:
Name View
quinidine View
levodopa View
dyskinesia View
parkinsons disease View
AVP-923 View
dextromethorphan View